ID   GSHB_HUMAN              Reviewed;         474 AA.
AC   P48637; B2R697; B6F210; E1P5P9; Q4TTD9;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   12-APR-2017, entry version 176.
DE   RecName: Full=Glutathione synthetase;
DE            Short=GSH synthetase;
DE            Short=GSH-S;
DE            EC=6.3.2.3;
DE   AltName: Full=Glutathione synthase;
GN   Name=GSS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7646467; DOI=10.1042/bj3100353;
RA   Gali R.R., Board P.G.;
RT   "Sequencing and expression of a cDNA for human glutathione
RT   synthetase.";
RL   Biochem. J. 310:353-358(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=19672693; DOI=10.1007/s11033-009-9675-3;
RA   Uchida M., Sugaya M., Kanamaru T., Hisatomi H.;
RT   "Alternative RNA splicing in expression of the glutathione synthetase
RT   gene in human cells.";
RL   Mol. Biol. Rep. 37:2105-2109(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RA   Shi Z.-Z., Galang R.L., Habib G.M., Lebovitz R.M., Lieberman M.W.;
RL   Submitted (AUG-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLU-437.
RC   TISSUE=Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-236 AND GLU-437.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 26-34; 113-125; 142-158; 222-230; 254-267;
RP   274-283; 294-305; 419-434 AND 453-474, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-474 IN COMPLEX WITH ADP
RP   AND GLUTATHIONE, COFACTOR, AND SUBUNIT.
RX   PubMed=10369661; DOI=10.1093/emboj/18.12.3204;
RA   Polekhina G., Board P.G., Gali R.R., Rossjohn J., Parker M.W.;
RT   "Molecular basis of glutathione synthetase deficiency and a rare gene
RT   permutation event.";
RL   EMBO J. 18:3204-3213(1999).
RN   [16]
RP   VARIANTS GSS DEFICIENCY GLY-219; TRP-267 AND CYS-283.
RX   PubMed=8896573; DOI=10.1038/ng1196-361;
RA   Shi Z.-Z., Habib G.M., Rhead W.J., Gahl W.A., He X., Sazer S.,
RA   Lieberman M.W.;
RT   "Mutations in the glutathione synthetase gene cause 5-oxoprolinuria.";
RL   Nat. Genet. 14:361-365(1996).
RN   [17]
RP   VARIANTS GSS DEFICIENCY.
RX   PubMed=9215686; DOI=10.1093/hmg/6.7.1147;
RA   Dahl N., Pigg M., Ristoff E., Gali R., Carlsson B., Mannervik B.,
RA   Larsson A., Board P.;
RT   "Missense mutations in the human glutathione synthetase gene result in
RT   severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and
RT   neurological dysfunction.";
RL   Hum. Mol. Genet. 6:1147-1152(1997).
CC   -!- CATALYTIC ACTIVITY: ATP + gamma-L-glutamyl-L-cysteine + glycine =
CC       ADP + phosphate + glutathione.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10369661};
CC       Note=Binds 1 Mg(2+) ion per subunit.
CC       {ECO:0000269|PubMed:10369661};
CC   -!- PATHWAY: Sulfur metabolism; glutathione biosynthesis; glutathione
CC       from L-cysteine and L-glutamate: step 2/2.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10369661}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-2969145, EBI-2969145;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-2969145, EBI-710997;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P48637-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48637-2; Sequence=VSP_047617;
CC         Note=Detected in colon, kidney, lung, liver, placenta,
CC         peripheral blood and uterus, but not in heart, skeletal muscle
CC         and spleen.;
CC   -!- DISEASE: Glutathione synthetase deficiency (GSS deficiency)
CC       [MIM:266130]: Severe form characterized by an increased rate of
CC       hemolysis and defective function of the central nervous system.
CC       {ECO:0000269|PubMed:8896573, ECO:0000269|PubMed:9215686}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Glutathione synthetase deficiency of erythrocytes
CC       (GLUSYNDE) [MIM:231900]: Mild form causing hemolytic anemia.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the eukaryotic GSH synthase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gss/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42531; AAA69492.1; -; mRNA.
DR   EMBL; AB459500; BAG75452.1; -; mRNA.
DR   EMBL; U34683; AAB62390.1; -; mRNA.
DR   EMBL; AK312492; BAG35394.1; -; mRNA.
DR   EMBL; DQ074975; AAY57328.1; -; Genomic_DNA.
DR   EMBL; AL133324; CAB93423.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76239.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76240.1; -; Genomic_DNA.
DR   EMBL; BC007927; AAH07927.1; -; mRNA.
DR   CCDS; CCDS13245.1; -. [P48637-1]
DR   PIR; S56748; S56748.
DR   RefSeq; NP_000169.1; NM_000178.3. [P48637-1]
DR   RefSeq; NP_001309423.1; NM_001322494.1. [P48637-1]
DR   RefSeq; NP_001309424.1; NM_001322495.1. [P48637-1]
DR   UniGene; Hs.82327; -.
DR   PDB; 2HGS; X-ray; 2.10 A; A=1-474.
DR   PDBsum; 2HGS; -.
DR   ProteinModelPortal; P48637; -.
DR   SMR; P48637; -.
DR   BioGrid; 109192; 27.
DR   IntAct; P48637; 3.
DR   MINT; MINT-5001027; -.
DR   STRING; 9606.ENSP00000216951; -.
DR   DrugBank; DB06151; Acetylcysteine.
DR   DrugBank; DB03408; gamma-Glutamylcysteine.
DR   DrugBank; DB00143; Glutathione.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB00151; L-Cysteine.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   iPTMnet; P48637; -.
DR   PhosphoSitePlus; P48637; -.
DR   BioMuta; GSS; -.
DR   DMDM; 1346191; -.
DR   OGP; P48637; -.
DR   REPRODUCTION-2DPAGE; IPI00010706; -.
DR   EPD; P48637; -.
DR   PaxDb; P48637; -.
DR   PeptideAtlas; P48637; -.
DR   PRIDE; P48637; -.
DR   DNASU; 2937; -.
DR   Ensembl; ENST00000216951; ENSP00000216951; ENSG00000100983. [P48637-1]
DR   Ensembl; ENST00000451957; ENSP00000407517; ENSG00000100983. [P48637-2]
DR   GeneID; 2937; -.
DR   KEGG; hsa:2937; -.
DR   UCSC; uc010zuo.3; human. [P48637-1]
DR   CTD; 2937; -.
DR   DisGeNET; 2937; -.
DR   GeneCards; GSS; -.
DR   HGNC; HGNC:4624; GSS.
DR   HPA; HPA054508; -.
DR   HPA; HPA059315; -.
DR   MalaCards; GSS; -.
DR   MIM; 231900; phenotype.
DR   MIM; 266130; phenotype.
DR   MIM; 601002; gene.
DR   neXtProt; NX_P48637; -.
DR   OpenTargets; ENSG00000100983; -.
DR   Orphanet; 289846; Glutathione synthetase deficiency with 5-oxoprolinuria.
DR   Orphanet; 289849; Glutathione synthetase deficiency without 5-oxoprolinuria.
DR   PharmGKB; PA29015; -.
DR   eggNOG; KOG0021; Eukaryota.
DR   eggNOG; ENOG410XPHH; LUCA.
DR   GeneTree; ENSGT00390000013764; -.
DR   HOGENOM; HOG000172641; -.
DR   HOVERGEN; HBG002458; -.
DR   InParanoid; P48637; -.
DR   KO; K01920; -.
DR   OMA; YMPRQYS; -.
DR   OrthoDB; EOG091G05V8; -.
DR   PhylomeDB; P48637; -.
DR   TreeFam; TF105187; -.
DR   BioCyc; MetaCyc:HS02174-MONOMER; -.
DR   BRENDA; 6.3.2.3; 2681.
DR   Reactome; R-HSA-174403; Glutathione synthesis and recycling.
DR   SABIO-RK; P48637; -.
DR   UniPathway; UPA00142; UER00210.
DR   ChiTaRS; GSS; human.
DR   EvolutionaryTrace; P48637; -.
DR   GenomeRNAi; 2937; -.
DR   PRO; PR:P48637; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000100983; -.
DR   CleanEx; HS_GSS; -.
DR   ExpressionAtlas; P48637; baseline and differential.
DR   Genevisible; P48637; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0043295; F:glutathione binding; IDA:UniProtKB.
DR   GO; GO:0004363; F:glutathione synthase activity; TAS:Reactome.
DR   GO; GO:0016594; F:glycine binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0006750; P:glutathione biosynthetic process; TAS:Reactome.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0031667; P:response to nutrient levels; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR   CDD; cd00228; eu-GS; 1.
DR   Gene3D; 1.10.1080.10; -; 2.
DR   Gene3D; 3.30.1490.50; -; 1.
DR   Gene3D; 3.30.1490.80; -; 1.
DR   Gene3D; 3.40.50.1760; -; 1.
DR   InterPro; IPR004887; Glutathione_synth_subst-bd_euk.
DR   InterPro; IPR005615; Glutathione_synthase.
DR   InterPro; IPR014042; Glutathione_synthase_a-hlx_euk.
DR   InterPro; IPR014709; Glutathione_synthase_dom.
DR   InterPro; IPR014049; Glutathione_synthase_N_euk.
DR   InterPro; IPR016185; PreATP-grasp_dom.
DR   PANTHER; PTHR11130; PTHR11130; 1.
DR   Pfam; PF03917; GSH_synth_ATP; 1.
DR   Pfam; PF03199; GSH_synthase; 1.
DR   PIRSF; PIRSF001558; GSHase; 1.
DR   SUPFAM; SSF52440; SSF52440; 1.
DR   TIGRFAMs; TIGR01986; glut_syn_euk; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Glutathione biosynthesis; Hereditary hemolytic anemia; Ligase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    474       Glutathione synthetase.
FT                                /FTId=PRO_0000211260.
FT   NP_BIND     364    373       ATP.
FT   NP_BIND     398    401       ATP.
FT   REGION      148    151       Substrate binding.
FT   REGION      214    216       Substrate binding.
FT   REGION      267    270       Substrate binding.
FT   REGION      461    462       Substrate binding.
FT   METAL       144    144       Magnesium.
FT   METAL       146    146       Magnesium.
FT   METAL       368    368       Magnesium.
FT   BINDING     125    125       Substrate.
FT   BINDING     144    144       ATP.
FT   BINDING     220    220       Substrate.
FT   BINDING     305    305       ATP.
FT   BINDING     375    375       ATP.
FT   BINDING     425    425       ATP.
FT   BINDING     450    450       Substrate.
FT   BINDING     452    452       ATP.
FT   BINDING     458    458       ATP; via carbonyl oxygen.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES     415    415       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      93    203       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:19672693}.
FT                                /FTId=VSP_047617.
FT   VARIANT      26     26       A -> D (in GSS deficiency;
FT                                dbSNP:rs759253242).
FT                                /FTId=VAR_003602.
FT   VARIANT     188    188       L -> P (in GSS deficiency; 100-fold
FT                                reduction of activity).
FT                                /FTId=VAR_003603.
FT   VARIANT     219    219       D -> A (in GSS deficiency).
FT                                /FTId=VAR_003604.
FT   VARIANT     219    219       D -> G (in GSS deficiency;
FT                                dbSNP:rs28938472).
FT                                {ECO:0000269|PubMed:8896573}.
FT                                /FTId=VAR_003605.
FT   VARIANT     236    236       R -> Q (in dbSNP:rs34239729).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025047.
FT   VARIANT     254    254       L -> R (in GSS deficiency).
FT                                /FTId=VAR_003606.
FT   VARIANT     267    267       R -> W (in GSS deficiency;
FT                                dbSNP:rs121909308).
FT                                {ECO:0000269|PubMed:8896573}.
FT                                /FTId=VAR_003607.
FT   VARIANT     270    270       Y -> C (in GSS deficiency; 100-fold
FT                                reduction of activity).
FT                                /FTId=VAR_003608.
FT   VARIANT     270    270       Y -> H (in GSS deficiency; 100-fold
FT                                reduction of activity).
FT                                /FTId=VAR_003609.
FT   VARIANT     283    283       R -> C (in GSS deficiency; 10-fold
FT                                reduction of activity;
FT                                dbSNP:rs121909309).
FT                                {ECO:0000269|PubMed:8896573}.
FT                                /FTId=VAR_003610.
FT   VARIANT     286    286       L -> Q (in GSS deficiency).
FT                                /FTId=VAR_003611.
FT   VARIANT     330    330       R -> C (in GSS deficiency;
FT                                dbSNP:rs148640446).
FT                                /FTId=VAR_003612.
FT   VARIANT     437    437       K -> E (in dbSNP:rs34852238).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025048.
FT   VARIANT     464    464       G -> V (in GSS deficiency).
FT                                /FTId=VAR_003613.
FT   VARIANT     469    469       D -> E (in GSS deficiency).
FT                                /FTId=VAR_003614.
FT   HELIX         6      9       {ECO:0000244|PDB:2HGS}.
FT   HELIX        12     28       {ECO:0000244|PDB:2HGS}.
FT   STRAND       32     34       {ECO:0000244|PDB:2HGS}.
FT   STRAND       43     47       {ECO:0000244|PDB:2HGS}.
FT   STRAND       50     53       {ECO:0000244|PDB:2HGS}.
FT   STRAND       56     58       {ECO:0000244|PDB:2HGS}.
FT   HELIX        59     67       {ECO:0000244|PDB:2HGS}.
FT   HELIX        69     81       {ECO:0000244|PDB:2HGS}.
FT   HELIX        83     91       {ECO:0000244|PDB:2HGS}.
FT   HELIX        93     96       {ECO:0000244|PDB:2HGS}.
FT   HELIX        98    113       {ECO:0000244|PDB:2HGS}.
FT   STRAND      119    132       {ECO:0000244|PDB:2HGS}.
FT   STRAND      134    136       {ECO:0000244|PDB:2HGS}.
FT   STRAND      138    146       {ECO:0000244|PDB:2HGS}.
FT   HELIX       153    158       {ECO:0000244|PDB:2HGS}.
FT   HELIX       160    169       {ECO:0000244|PDB:2HGS}.
FT   HELIX       173    176       {ECO:0000244|PDB:2HGS}.
FT   HELIX       184    199       {ECO:0000244|PDB:2HGS}.
FT   STRAND      205    209       {ECO:0000244|PDB:2HGS}.
FT   HELIX       217    228       {ECO:0000244|PDB:2HGS}.
FT   TURN        229    231       {ECO:0000244|PDB:2HGS}.
FT   STRAND      234    237       {ECO:0000244|PDB:2HGS}.
FT   HELIX       239    245       {ECO:0000244|PDB:2HGS}.
FT   STRAND      246    248       {ECO:0000244|PDB:2HGS}.
FT   STRAND      254    256       {ECO:0000244|PDB:2HGS}.
FT   STRAND      259    268       {ECO:0000244|PDB:2HGS}.
FT   HELIX       272    274       {ECO:0000244|PDB:2HGS}.
FT   HELIX       277    288       {ECO:0000244|PDB:2HGS}.
FT   STRAND      289    295       {ECO:0000244|PDB:2HGS}.
FT   HELIX       297    301       {ECO:0000244|PDB:2HGS}.
FT   HELIX       305    310       {ECO:0000244|PDB:2HGS}.
FT   HELIX       316    320       {ECO:0000244|PDB:2HGS}.
FT   HELIX       325    333       {ECO:0000244|PDB:2HGS}.
FT   STRAND      338    340       {ECO:0000244|PDB:2HGS}.
FT   STRAND      342    344       {ECO:0000244|PDB:2HGS}.
FT   HELIX       345    356       {ECO:0000244|PDB:2HGS}.
FT   HELIX       358    360       {ECO:0000244|PDB:2HGS}.
FT   STRAND      361    366       {ECO:0000244|PDB:2HGS}.
FT   STRAND      369    371       {ECO:0000244|PDB:2HGS}.
FT   HELIX       376    386       {ECO:0000244|PDB:2HGS}.
FT   HELIX       390    394       {ECO:0000244|PDB:2HGS}.
FT   STRAND      395    399       {ECO:0000244|PDB:2HGS}.
FT   STRAND      406    411       {ECO:0000244|PDB:2HGS}.
FT   STRAND      418    435       {ECO:0000244|PDB:2HGS}.
FT   STRAND      438    453       {ECO:0000244|PDB:2HGS}.
FT   TURN        461    464       {ECO:0000244|PDB:2HGS}.
FT   STRAND      467    469       {ECO:0000244|PDB:2HGS}.
FT   STRAND      472    474       {ECO:0000244|PDB:2HGS}.
SQ   SEQUENCE   474 AA;  52385 MW;  3C25EF7072EFE058 CRC64;
     MATNWGSLLQ DKQQLEELAR QAVDRALAEG VLLRTSQEPT SSEVVSYAPF TLFPSLVPSA
     LLEQAYAVQM DFNLLVDAVS QNAAFLEQTL SSTIKQDDFT ARLFDIHKQV LKEGIAQTVF
     LGLNRSDYMF QRSADGSPAL KQIEINTISA SFGGLASRTP AVHRHVLSVL SKTKEAGKIL
     SNNPSKGLAL GIAKAWELYG SPNALVLLIA QEKERNIFDQ RAIENELLAR NIHVIRRTFE
     DISEKGSLDQ DRRLFVDGQE IAVVYFRDGY MPRQYSLQNW EARLLLERSH AAKCPDIATQ
     LAGTKKVQQE LSRPGMLEML LPGQPEAVAR LRATFAGLYS LDVGEEGDQA IAEALAAPSR
     FVLKPQREGG GNNLYGEEMV QALKQLKDSE ERASYILMEK IEPEPFENCL LRPGSPARVV
     QCISELGIFG VYVRQEKTLV MNKHVGHLLR TKAIEHADGG VAAGVAVLDN PYPV
//
